所有静脉血栓是多因素的,由Virchow三联征的组成: 非肝硬化病人门静脉血栓可能没有门静脉血流下降的因素...
...
肝( 窦) 前型非肝硬化门静脉高压症( non - cirrhotic portal hypertension,NCPH) 是一组预后可能较好、病因少见或复杂的门静脉系统或全身性疾病,肝脏功能基本正常、肝 静 脉 压 力 梯 度 ( hepatic venous pressure gradient,HVPG) 正常或轻度增加为特征...
Pre-sinusoidal 窦前性 Sinusoidal 窦性 Post-sinusoida l窦后性 Porto-sinusoidal vascular disease (PSVD) Drug-induced Budd-Chiari syndrome Portal vein obstruction (neoplastic and non-neoplastic) Alcoholic liver damage Veno-occlusive disease S...
When to Suspect PSVD? 何时怀疑PSVD? There are two clinical scenarios in whom PSVD can be suspected: patients with chronic and unexplained alteration of liver enzymes without portal hypertension and patients with unexplained clinically evi...
The term non-cirrhotic portal hypertension (NCPH) refers to a heterogeneous group of liver disorders that primarily affect the liver vascular system and that are classified anatomically on the basis of site of resistance to blood flow, as...
Porto sinusoidal vascular liver disease (PSVD) is a vascular liver disease characterized by portal hypertension in the absence of cirrhosis and other causes of liver disease[1]. 门窦性血管性肝病(PSVD)是一种以血管性肝病为特征的门静脉高压,...
发病机制 到目前为止,INCPH 的具体病理生理机制尚不 明确。分二元理论和统一理论 二元理论: 认为,肝内血管闭塞所致 门静脉血流阻力增加和脾大继发门静脉血流增加是 导致 INCPH 患者门静脉高压的两个主要因素。肝 内血管闭塞的具体原因尚不清楚 统一理论:...
INCPH 在世界各地都有报道,它在西方较为罕 见,而在发展中国家,其发病率更高。性别比例在不同国家有所不同,在西方国家和印度多见于男 性,而在日本则多发于女性。发病年龄不定,在印度,其发病年龄约 25 ~ 35 岁,在日本,其发病年龄约 50 岁,而 在 西...
Non-tumoral PVT is the most common thrombotic event in patients with cirrhosis, with an annual incidence of up to 12%[127,128]. 非肿瘤性PVT是肝硬化患者中最常见的血栓性事件,每年的发病率高达12%的[127,128]。 Asymptomatic presentation is comm...